| Mrs Dana Elizabeth Buccellato, | |
|
2307 Steinway St Apt 2f, Astoria, NY 11105-1950 | |
| (845) 729-8146 | |
| Not Available |
| Full Name | Mrs Dana Elizabeth Buccellato |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 2307 Steinway St Apt 2f, Astoria, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093114944 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Dana Elizabeth Buccellato, 2307 Steinway St Apt 2f, Astoria, NY 11105-1950 Ph: (845) 729-8146 | Mrs Dana Elizabeth Buccellato, 2307 Steinway St Apt 2f, Astoria, NY 11105-1950 Ph: (845) 729-8146 |
News Archive
Novasep, a leading supplier of services and technologies for the life sciences industry, today announces it will build a fully integrated Antibody Drug Conjugate (ADC) facility at its Le Mans site in France. The new facility will enable Novasep to complement its current ADC offering with full bio-conjugation services to meet increasing market demand.
Biomedical engineers at Duke University have shown that the efficacy of a two-pronged type 2 diabetes treatment increases when the drugs are linked by a heat-sensitive tether rather than simply concurrently administered.
The Alzheimer's Drug Discovery Foundation announced today the first group of researchers who will receive funding through its Diagnostics Accelerator, a new research program that aims to fast-track the development of diagnostic tools and biomarkers for Alzheimer's disease and related dementias.
Peanut allergy sufferers and their parents take note: a Johns Hopkins Children's Center study finds that most soaps and household cleaners will remove enough peanut allergen from hands and dining surfaces at home and in schools to prevent an attack.
NovoStent® Corporation, a privately held medical device company, today announced that it has received CE Mark for its SAMBATM Stent and Delivery System for the treatment of peripheral artery disease. The SAMBA Stent was designed to treat the highly varied presentation of atherosclerotic disease in the superficial femoral (SFA) and popliteal arteries by providing a unique combination of strength, flexibility and vessel coverage.
› Verified 1 days ago
Mrs. Dalia Avezbadalov, M.S., CCC-SLP, TSSLD Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3711 35th Ave, 3rd Floor, Astoria, NY 11101 Phone: 718-706-7500 | |
Julie Morris, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2258 41st St Apt 2r, Astoria, NY 11105 Phone: 860-305-4697 | |
Nicole Jennifer Tarone, Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 3711 35th Ave, Astoria, NY 11101 Phone: 718-706-7500 Fax: 718-706-9595 | |
Miss Trista De Falco, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3636 33rd St, Astoria, NY 11106 Phone: 212-589-1203 | |
Diane Wiener, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2534 Steinway St, Astoria, NY 11103 Phone: 718-777-5243 Fax: 718-777-5250 | |
Mrs. Lori Rachel Berg, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 30-15 29th St, Ps 234, Astoria, NY 11102 Phone: 516-314-5999 |